Clear Labs Secures $30 Million in Series D Financing to Accelerate Development and Adoption of Cutting-Edge Sequencing Solutions
Summary
"Clear Labs is revolutionizing the NGS industry by providing a seamless platform that combines robotics, bioinformatics, and DNA sequencing," said Greg Yap, Partner at Menlo Ventures. "Their technology sets a new standard for speed, efficiency, and simplicity for NGS testing while reducing costs and making high-quality diagnostics accessible to more institutions. Were proud to continue supporting Sasan and the Clear Labs team because we know they are delivering the clarity needed to help inform healthcare decisions and protect lives." With this news, Clear Labs is adding Kevin Keegan, Becton Dickinsons Vice President and Global Platform Leader, Molecular Diagnostics, to its Board of Directors. "Kevin adds to our impressive pedigree of talented team members, and his industry insights and operational expertise will help Clear Labs continue to evolve to meet new needs.